1.	Phase II/III Randomized Study of Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) Versus Pilocarpine Hydrochloride in Head and Neck Cancer Patients With Early Radiotherapy-Induced Xerostomia Phase: Phase III, Phase II Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-0537, RTOG 0537, NCT00656513
2.	Phase III Study of the Prophylactic Use of Oral Pilocarpine to Reduce Hyposalivation and Mucositis Associated with Curative Radiation Therapy in Patients with Head and Neck Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-9709, NCI-P97-0121, NCT00003139
3.	Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: HN-04-0010, NCT00168181
4.	Phase III Randomized Study of Pilocarpine Hydrochloride for Vaginal Dryness in Patients With Breast Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N04CA, NCT00343382
5.	Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids Phase: Phase III Type: Supportive care Status: Completed Age: 16 and over Sponsor: Other Protocol IDs: SC16, CAN-NCIC-SC16, P-UPJOHN-CAN-NCIC-SC16, CDR0000066788, NCT00003686